Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephen Thomas Sonis, D.M.Sc., D.M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Effects of Sphingomyelinase Inhibitor on Ionizing Radiation-Induced Apoptosis
Part Time/Continuation, 01/03/01 - 05/31/01
The Role of Endothelial Cell Injury in the Development of Oral Mucositis
Part Time/Continuation, 09/01/00 - 12/31/00
The Rold of Endothelial Cell Injury in the Development of Oral Mucositis
Summer, 06/23/00 - 08/31/00
Treatment of Radiotherapy-Induced Oral Mucositis with In Vivo Blockade of Tumor Necrosis Factor
Part Time/Continuation, 08/01/99 - 06/30/00
Mucositis Research
Summer, 07/01/03 - 08/31/03
Oral Disease and Dental Treatment for Patients Undergoing Cardiac Valve Replacements of Surgical Valve Repair
Part Time, 09/05/01 - 01/31/02
Effects of Sphingomyelinase Inhibitor on Ionizing Radiation-induced Apoptosis
Summer, 06/21/00 - 08/30/00
Development of a Murine Model of Chemotherapy-induced Ulcerative Mucositis and the Treatment of Oral Mucositis with In Vivo Blockade of Tumor Necrosis Factor-X
Part Time/Continuation, 10/01/98 - 06/30/99
Effects of Sphingomyelinase Inhibitor on Ionizing Radiation-Induced Apoptosis
Part Time/Continuation, 09/01/00 - 12/31/00
Therapy-Related Oral and Maxillofacial Complications in Hodgkin’s Lymphoma Survivors: A Sib-Pair Analysis
Summer, 06/15/09 - 08/10/09

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R13DE013663 (SONIS, STEPHEN T) May 1, 2000 - Apr 30, 2001
    NIH
    MUCOSAL INJURY IN CANCER PATIENTS
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sonis S, Villa A, Epstein J. Exceptional toxicity resistance. Support Care Cancer. 2021 May; 29(5):2263-2264. PMID: 33594509.
    Citations:    Fields:    
  2. Villa A, Vollemans M, De Moraes A, Sonis S. Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers. Support Care Cancer. 2021 Mar 31. PMID: 33788003.
    Citations:    Fields:    
  3. Pulsipher A, Savage JR, Kennedy TP, Gupta K, Cuiffo BG, Sonis ST, Lee WY. GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling. PLoS One. 2021; 16(3):e0249343. PMID: 33770116.
    Citations:    Fields:    
  4. Sonis ST. A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment. Support Care Cancer. 2021 Mar 13. PMID: 33712912.
    Citations:    Fields:    
  5. Sonis ST. Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Induced Mucositis. Drug Des Devel Ther. 2021; 15:1021-1029. PMID: 33716500.
    Citations:    Fields:    
  6. Sonis ST. Treatment for Oral Mucositis-Current Options and an Update of Small Molecules Under Development. Curr Treat Options Oncol. 2021 Feb 17; 22(3):25. PMID: 33595722.
    Citations:    Fields:    
  7. Xu Y, Wen N, Sonis ST, Villa A. Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana-Farber Cancer Institute, 2011 to 2019. Cancer. 2021 Feb 17. PMID: 33595843.
    Citations:    Fields:    
  8. Choi SE, Choudhary A, Sonis S, Villa A. Benefits of the Involvement of Dentists in Managing Oral Complications Among Patients With Oral Cavity and Oropharyngeal Cancer: An Analysis of Claims Data. JCO Oncol Pract. 2021 Feb 08; OP2000892. PMID: 33555929.
    Citations:    
  9. Sankaran SP, Sonis S. Network meta-analysis from a pairwise meta-analysis design: to assess the comparative effectiveness of oral care interventions in preventing ventilator-associated pneumonia in critically ill patients. Clin Oral Investig. 2021 Feb 03. PMID: 33537946.
    Citations:    Fields:    
  10. Epstein JB, Dean DR, Sonis ST. Industry and MASCC-an opportunity not to be missed. Support Care Cancer. 2021 Feb; 29(2):559-561. PMID: 33215315.
    Citations:    Fields:    
  11. Wardill HR, Sonis ST, Blijlevens NMA, Van Sebille YZA, Ciorba MA, Loeffen EAH, Cheng KKF, Bossi P, Porcello L, Castillo DA, Elad S, Bowen JM. Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer. 2020 Nov; 28(11):5059-5073. PMID: 32592033.
    Citations:    Fields:    Translation:Humans
  12. Satheeshkumar PS, Papatheodorou S, Sonis S. Enhanced oral hygiene interventions as a risk mitigation strategy for the prevention of non-ventilator-associated pneumonia: a systematic review and meta-analysis. Br Dent J. 2020 04; 228(8):615-622. PMID: 32332964.
    Citations: 2     Fields:    Translation:Humans
  13. Sonis S. Correction to: Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity? Support Care Cancer. 2020 Apr; 28(4):2033. PMID: 32025916.
    Citations:    Fields:    
  14. Cernea A, Fernández-Martínez JL, deAndrés-Galiana EJ, Fernández-Ovies FJ, Alvarez-Machancoses O, Fernández-Muñiz Z, Saligan LN, Sonis ST. Robust pathway sampling in phenotype prediction. Application to triple negative breast cancer. BMC Bioinformatics. 2020 Mar 11; 21(Suppl 2):89. PMID: 32164540.
    Citations: 1     Fields:    Translation:Humans
  15. Villa A, Sonis ST. An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis. Expert Opin Pharmacother. 2020 Apr; 21(5):541-548. PMID: 31990597.
    Citations: 1     Fields:    Translation:Humans
  16. Sonis S. Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity? Support Care Cancer. 2020 02; 28(2):423-424. PMID: 31720803.
    Citations: 1     Fields:    
  17. Giralt J, Tao Y, Kortmann RD, Zasadny X, Contreras-Martinez J, Ceruse P, Arias de la Vega F, Lalla RV, Ozsahin EM, Pajkos G, Mazar A, Attali P, Bossi P, Vasseur B, Sonis S, Henke M, Bensadoun RJ. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2020 02 01; 106(2):320-328. PMID: 31669562.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  18. Anderson CM, Lee CM, Saunders DP, Curtis A, Dunlap N, Nangia C, Lee AS, Gordon SM, Kovoor P, Arevalo-Araujo R, Bar-Ad V, Peddada A, Colvett K, Miller D, Jain AK, Wheeler J, Blakaj D, Bonomi M, Agarwala SS, Garg M, Worden F, Holmlund J, Brill JM, Downs M, Sonis ST, Katz S, Buatti JM. Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer. J Clin Oncol. 2019 12 01; 37(34):3256-3265. PMID: 31618127.
    Citations: 9     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  19. Gupta A, Sonis S, Uppaluri R, Bergmark RW, Villa A. Disparities in Oral Cancer Screening Among Dental Professionals: NHANES 2011-2016. Am J Prev Med. 2019 10; 57(4):447-457. PMID: 31443957.
    Citations: 1     Fields:    Translation:Humans
  20. Lalla RV, Brennan MT, Gordon SM, Sonis ST, Rosenthal DI, Keefe DM. Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy. J Natl Cancer Inst Monogr. 2019 08 01; 2019(53). PMID: 31425601.
    Citations: 5     Fields:    Translation:Humans
  21. Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, Bateman E, Correa ME, Raber-Durlacher J, Kandwal A, Mayo B, Nair RG, Stringer A, Ten Bohmer K, Thorpe D, Lalla RV, Sonis S, Cheng K, Elad S. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019 Oct; 27(10):4023-4033. PMID: 31286231.
    Citations: 10     Fields:    Translation:Humans
  22. Ridner SH, Dietrich MS, Sonis ST, Murphy B. Biomarkers Associated with Lymphedema and Fibrosis in Patients with Cancer of the Head and Neck. Lymphat Res Biol. 2018 Nov 28. PMID: 30484735.
    Citations: 1     Fields:    
  23. Bachour PC, Sonis ST. Predicting mucositis risk associated with cytotoxic cancer treatment regimens: rationale, complexity, and challenges. Curr Opin Support Palliat Care. 2018 06; 12(2):198-210. PMID: 29547492.
    Citations: 2     Fields:    Translation:Humans
  24. Villa A, Sonis S. Oral leukoplakia remains a challenging condition. Oral Dis. 2018 Mar; 24(1-2):179-183. PMID: 29480606.
    Citations: 6     Fields:    Translation:Humans
  25. Sonis ST, Villa A. Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis. Expert Opin Investig Drugs. 2018 02; 27(2):147-154. PMID: 29323575.
    Citations: 3     Fields:    Translation:HumansAnimalsPHPublic Health
  26. Reinbolt RE, Sonis S, Timmers CD, Fernández-Martínez JL, Cernea A, de Andrés-Galiana EJ, Hashemi S, Miller K, Pilarski R, Lustberg MB. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm. Cancer Med. 2018 01; 7(1):240-253. PMID: 29168353.
    Citations: 5     Fields:    Translation:Humans
  27. Gupta A, Sonis ST, Schneider EB, Villa A. Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns. Cancer. 2018 02 15; 124(4):760-768. PMID: 29112234.
    Citations: 4     Fields:    Translation:Humans
  28. Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 11; 22(11):1413. PMID: 29123016.
    Citations:    Fields:    
  29. Anderson CM, Sonis ST, Lee CM, Adkins D, Allen BG, Sun W, Agarwala SS, Venigalla ML, Chen Y, Zhen W, Mould DR, Holmlund JT, Brill JM, Buatti JM. Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):427-435. PMID: 29174131.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  30. Hashemi S, Fernandez Martinez JL, Saligan L, Sonis S. Exploring Genetic Attributions Underlying Radiotherapy-Induced Fatigue in Prostate Cancer Patients. J Pain Symptom Manage. 2017 09; 54(3):326-339. PMID: 28797855.
    Citations:    Fields:    Translation:Humans
  31. Kuten-Shorrer M, Treister NS, Stock S, Kelley JM, Ji YD, Woo SB, Lerman MA, Palmason S, Sonis ST, Villa A. Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study. J Oral Facial Pain Headache. 2017 Summer; 31(3):257-263. PMID: 28738111.
    Citations: 1     Translation:Humans
  32. Sultan AS, Zimering Y, Petruzziello G, Alyea EP, Antin JH, Soiffer RJ, Ho VT, Sonis ST, Woo SB, Marty FM, Treister NS. Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Sep; 124(3):253-260. PMID: 28823316.
    Citations: 5     Fields:    Translation:Humans
  33. Cinausero M, Aprile G, Ermacora P, Basile D, Vitale MG, Fanotto V, Parisi G, Calvetti L, Sonis ST. New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Front Pharmacol. 2017; 8:354. PMID: 28642709.
    Citations: 18     
  34. Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, Bonomi M, Scott Z, Elder J, Sonis ST, Straube R, Donini O. Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients. Biotechnol Rep (Amst). 2017 Sep; 15:24-26. PMID: 28649557.
    Citations: 2     
  35. Kuten-Shorrer M, Treister NS, Stock S, Kelley JM, Ji YD, Woo SB, Lerman MA, Palmason S, Sonis ST, Villa A. Safety and tolerability of topical clonazepam solution for management of oral dysesthesia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Aug; 124(2):146-151. PMID: 28606830.
    Citations:    Fields:    Translation:Humans
  36. Sonis ST. The Chicken or the Egg? Changes in Oral Microbiota as Cause or Consequence of Mucositis During Radiation Therapy. EBioMedicine. 2017 Apr; 18:7-8. PMID: 28330600.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  37. Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 03; 22(3):343-350. PMID: 28209748.
    Citations: 8     Fields:    Translation:Humans
  38. Kim DW, Garon EB, Jatoi A, Keefe DM, Lacouture ME, Sonis S, Gernhardt D, Wang T, Giri N, Doherty JP, Nadanaciva S, O'Connell J, Sbar E, Cho BC. Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042). Lung Cancer. 2017 04; 106:76-82. PMID: 28285698.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  39. Sonis S, Andreotta PW, Lyng G. On the pathogenesis of mTOR inhibitor-associated stomatitis (mIAS)-studies using an organotypic model of the oral mucosa. Oral Dis. 2017 Apr; 23(3):347-352. PMID: 27896917.
    Citations: 4     Fields:    Translation:Humans
  40. Fernández-Martínez JL, deAndrés-Galiana EJ, Sonis ST. Genomic data integration in chronic lymphocytic leukemia. J Gene Med. 2017 Jan; 19(1-2). PMID: 27928896.
    Citations: 4     Fields:    Translation:HumansCells
  41. deAndrés-Galiana EJ, Fernández-Martínez JL, Sonis ST. Sensitivity analysis of gene ranking methods in phenotype prediction. J Biomed Inform. 2016 12; 64:255-264. PMID: 27793724.
    Citations: 5     Fields:    Translation:Humans
  42. Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, Bonomi M, Elder J, Sonis ST, Straube R, Donini O. Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study. J Biotechnol. 2016 Dec 10; 239:115-125. PMID: 27746305.
    Citations: 11     Fields:    Translation:HumansAnimalsCTClinical Trials
  43. Deandrés-Galiana EJ, Fernández-Martínez JL, Saligan LN, Sonis ST. Impact of Microarray Preprocessing Techniques in Unraveling Biological Pathways. J Comput Biol. 2016 Dec; 23(12):957-968. PMID: 27494192.
    Citations: 3     Fields:    Translation:HumansCells
  44. Villa A, Sonis ST. Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin Pharmacother. 2016 Sep; 17(13):1801-7. PMID: 27477002.
    Citations: 8     Fields:    Translation:HumansAnimals
  45. Wardill HR, Mander KA, Van Sebille YZ, Gibson RJ, Logan RM, Bowen JM, Sonis ST. Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer. 2016 Dec 15; 139(12):2635-2645. PMID: 27367824.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
  46. Sonis ST. Ultrasound-mediated drug delivery. Oral Dis. 2017 Mar; 23(2):135-138. PMID: 27171556.
    Citations: 1     Fields:    Translation:Humans
  47. deAndrés-Galiana EJ, Fernández-Martínez JL, Sonis ST. Design of Biomedical Robots for Phenotype Prediction Problems. J Comput Biol. 2016 08; 23(8):678-92. PMID: 27347715.
    Citations: 3     Fields:    Translation:Humans
  48. Villa A, Sonis S. Toxicities associated with head and neck cancer treatment and oncology-related clinical trials. Curr Probl Cancer. 2016 Sep - Dec; 40(5-6):244-257. PMID: 27520848.
    Citations: 2     Fields:    Translation:Humans
  49. Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB. A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer. Ann Oncol. 2016 09; 27(9):1712-8. PMID: 27287210.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  50. Chen P, Mancini M, Sonis ST, Fernandez-Martinez J, Liu J, Cohen EE, Toback FG. A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis. PLoS One. 2016; 11(4):e0152995. PMID: 27049860.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  51. Vasconcelos RM, Sanfilippo N, Paster BJ, Kerr AR, Li Y, Ramalho L, Queiroz EL, Smith B, Sonis ST, Corby PM. Host-Microbiome Cross-talk in Oral Mucositis. J Dent Res. 2016 07; 95(7):725-33. PMID: 27053118.
    Citations: 22     Fields:    Translation:Humans
  52. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer. 2016 06; 24(6):2781-92. PMID: 26984240.
    Citations: 35     Fields:    Translation:Humans
  53. Sonis ST, Amaral Mendes R. Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis? J Oral Pathol Med. 2016 Aug; 45(7):469-74. PMID: 26991523.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  54. Sonis ST, Hashemi S, Epstein JB, Nair RG, Raber-Durlacher JE. Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncol. 2016 Mar; 54:7-14. PMID: 26852286.
    Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
  55. Aprile G, Rihawi K, De Carlo E, Sonis ST. Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update. World J Gastroenterol. 2015 Nov 07; 21(41):11793-803. PMID: 26557003.
    Citations: 7     Fields:    Translation:HumansAnimals
  56. Lau A, Dodson TB, Sonis ST, Kaban LB. An Outcomes Study of 40 Years of Graduates of a General Practice Dental Residency. J Dent Educ. 2015 Aug; 79(8):888-96. PMID: 26246526.
    Citations:    Fields:    Translation:Humans
  57. Villa A, Sonis ST. Mucositis: pathobiology and management. Curr Opin Oncol. 2015 May; 27(3):159-64. PMID: 25774860.
    Citations: 47     Fields:    Translation:Humans
  58. Mawardi HH, Elbadawi LS, Sonis ST. Current understanding of the relationship between periodontal and systemic diseases. Saudi Med J. 2015 Feb; 36(2):150-8. PMID: 25719577.
    Citations: 8     Fields:    Translation:Humans
  59. Villa A, Stock S, Aboalela A, Lerman MA, Woo SB, Sonis ST, Treister NS. Oral Medicine referrals at a hospital-based practice in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Apr; 119(4):423-9. PMID: 25758844.
    Citations: 1     Fields:    Translation:Humans
  60. Sonis ST. Genomics, personalized medicine, and supportive cancer care. Am Soc Clin Oncol Educ Book. 2015; 9-16. PMID: 25993135.
    Citations: 2     Fields:    Translation:Humans
  61. Wardill HR, Van Sebille YZ, Mander KA, Gibson RJ, Logan RM, Bowen JM, Sonis ST. Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity. Cancer Treat Rev. 2015 Feb; 41(2):122-8. PMID: 25512119.
    Citations: 7     Fields:    Translation:HumansCells
  62. Villa A, Aboalela A, Luskin KA, Cutler CS, Sonis ST, Woo SB, Peterson DE, Treister NS. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease. Biol Blood Marrow Transplant. 2015 Mar; 21(3):503-8. PMID: 25482865.
    Citations: 2     Fields:    Translation:HumansCells
  63. Saligan LN, Fernández-Martínez JL, deAndrés-Galiana EJ, Sonis S. Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancer. Cancer Inform. 2014; 13:141-52. PMID: 25506196.
    Citations: 12     
  64. Lalla RV, Choquette LE, Curley KF, Dowsett RJ, Feinn RS, Hegde UP, Pilbeam CC, Salner AL, Sonis ST, Peterson DE. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer. Oral Oncol. 2014 Nov; 50(11):1098-103. PMID: 25151488.
    Citations: 6     Fields:    Translation:Humans
  65. Sonis S, Elting L, Keefe D, Nguyen H, Grunberg S, Randolph-Jackson P, Brennan M. Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung. Support Care Cancer. 2015 Feb; 23(2):433-9. PMID: 25123194.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  66. Yuan A, Sonis S. Emerging therapies for the prevention and treatment of oral mucositis. Expert Opin Emerg Drugs. 2014 Sep; 19(3):343-51. PMID: 25102771.
    Citations: 5     Fields:    Translation:HumansAnimals
  67. Keefe DM, Elting LS, Nguyen HT, Grunberg SM, Aprile G, Bonaventura A, Selva-Nayagam S, Barsevick A, Koczwara B, Sonis ST. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy. Cancer Chemother Pharmacol. 2014 Oct; 74(4):675-80. PMID: 25055935.
    Citations: 11     Fields:    Translation:Humans
  68. Allison RR, Ambrad AA, Arshoun Y, Carmel RJ, Ciuba DF, Feldman E, Finkelstein SE, Gandhavadi R, Heron DE, Lane SC, Longo JM, Meakin C, Papadopoulos D, Pruitt DE, Steinbrenner LM, Taylor MA, Wisbeck WM, Yuh GE, Nowotnik DP, Sonis ST. Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck. Cancer. 2014 May 01; 120(9):1433-40. PMID: 24877167.
    Citations: 13     Fields:    Translation:Humans
  69. Reisman SA, Lee CY, Meyer CJ, Proksch JW, Sonis ST, Ward KW. Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitis. Radiat Res. 2014 May; 181(5):512-20. PMID: 24720753.
    Citations: 24     Fields:    Translation:AnimalsCellsPHPublic Health
  70. Guze K, Pawluk HC, Short M, Zeng H, Lorch J, Norris C, Sonis S. Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. Head Neck. 2015 Apr; 37(4):511-7. PMID: 24677300.
    Citations: 21     Fields:    Translation:Humans
  71. Mancini ML, Sonis ST. Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities. Front Pharmacol. 2014; 5:51. PMID: 24734020.
    Citations: 16     
  72. Russi EG, Raber-Durlacher JE, Sonis ST. Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation. Mediators Inflamm. 2014; 2014:518261. PMID: 24757285.
    Citations: 12     Fields:    Translation:HumansCells
  73. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014 May 15; 120(10):1453-61. PMID: 24615748.
    Citations: 209     Fields:    Translation:Humans
  74. Treister NS, Sonis ST, Woo SB. Community-based dental evaluation program for hematopoietic cell transplantation. J Clin Oncol. 2013 Nov; 31(31_suppl):143. PMID: 28136436.
    Citations:    
  75. Kuten-Shorrer M, Kelley JM, Sonis ST, Treister NS. Placebo effect in burning mouth syndrome: a systematic review. Oral Dis. 2014 Apr; 20(3):e1-6. PMID: 24164777.
    Citations: 3     Fields:    Translation:Humans
  76. Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer. 2013 Dec 15; 119(24):4268-76. PMID: 24114811.
    Citations: 27     Fields:    Translation:HumansCellsCTClinical Trials
  77. Carlotto A, Hogsett VL, Maiorini EM, Razulis JG, Sonis ST. The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics. 2013 Sep; 31(9):753-66. PMID: 23963867.
    Citations: 30     Fields:    Translation:Humans
  78. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV. Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013 Nov; 21(11):3233-41. PMID: 23842598.
    Citations: 25     Fields:    Translation:Humans
  79. Sonis S, Antin J, Tedaldi M, Alterovitz G. SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients. Oral Dis. 2013 Oct; 19(7):721-7. PMID: 23809011.
    Citations: 11     Fields:    Translation:Humans
  80. Nicolatou-Galitis O, Nikolaidi A, Athanassiadis I, Papadopoulou E, Sonis S. Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Aug; 116(2):e110-6. PMID: 23643584.
    Citations: 6     Fields:    Translation:Humans
  81. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV. Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013 Jul; 21(7):2075-83. PMID: 23604521.
    Citations: 26     Fields:    Translation:Humans
  82. Chin M, Lee CY, Chuang JC, Bumeister R, Wigley WC, Sonis ST, Ward KW, Meyer C. Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of Type 2 diabetes and obesity. Am J Physiol Renal Physiol. 2013 Jun 15; 304(12):F1438-46. PMID: 23594825.
    Citations: 25     Fields:    Translation:Animals
  83. Martins F, de Oliveira MA, Wang Q, Sonis S, Gallottini M, George S, Treister N. A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients. Oral Oncol. 2013 Apr; 49(4):293-8. PMID: 23312237.
    Citations: 23     Fields:    Translation:Humans
  84. Sonis ST. Oral mucositis in head and neck cancer: risk, biology, and management. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714511.
    Citations: 17     Fields:    Translation:HumansAnimalsPHPublic Health
  85. Zombeck JA, Fey EG, Lyng GD, Sonis ST. A clinically translatable mouse model for chemotherapy-related fatigue. Comp Med. 2013; 63(6):491-7. PMID: 24326224.
    Citations: 17     Fields:    Translation:Animals
  86. Wu X, Chen P, Sonis ST, Lingen MW, Berger A, Toback FG. A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e409-15. PMID: 22420966.
    Citations: 7     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  87. Peterson DE, Keefe DM, Sonis ST. New frontiers in mucositis. Am Soc Clin Oncol Educ Book. 2012; 545-51. PMID: 24451793.
    Citations: 5     Fields:    
  88. Lalla RV, Gordon GB, Schubert M, Silverman S, Hutten M, Sonis ST, LeVeque F, Peterson DE. A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy. Support Care Cancer. 2012 Aug; 20(8):1797-804. PMID: 21964618.
    Citations: 7     Fields:    Translation:Humans
  89. Sonis S. The quest for effective treatments of mucositis. J Support Oncol. 2011 Sep-Oct; 9(5):170-1. PMID: 22024305.
    Citations: 2     Fields:    Translation:HumansAnimals
  90. de Oliveira MA, Martins E Martins F, Wang Q, Sonis S, Demetri G, George S, Butrynski J, Treister NS. Clinical presentation and management of mTOR inhibitor-associated stomatitis. Oral Oncol. 2011 Oct; 47(10):998-1003. PMID: 21890398.
    Citations: 23     Fields:    Translation:Humans
  91. Alterovitz G, Tuthill C, Rios I, Modelska K, Sonis S. Personalized medicine for mucositis: Bayesian networks identify unique gene clusters which predict the response to gamma-D-glutamyl-L-tryptophan (SCV-07) for the attenuation of chemoradiation-induced oral mucositis. Oral Oncol. 2011 Oct; 47(10):951-5. PMID: 21824803.
    Citations: 7     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  92. Sonis ST. Oral mucositis. Anticancer Drugs. 2011 Aug; 22(7):607-12. PMID: 21709615.
    Citations: 43     Fields:    Translation:HumansAnimalsPHPublic Health
  93. Chen P, Lingen M, Sonis ST, Walsh-Reitz MM, Toback FG. Role of AMP-18 in oral mucositis. Oral Oncol. 2011 Sep; 47(9):831-9. PMID: 21737340.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  94. Papkoff J, Lee H, Singh G, Singh S, Chitta S, Andrew K, Quintel P, Rosenberg JS, Watkins BA, Sonis ST, Tuthill CW. Identification of signaling pathways involved in the mechanism of action of the immunomodulatory peptide gamma-D-glutamyl-L-tryptophan. J Clin Oncol. 2011 May 20; 29(15_suppl):5591. PMID: 28022063.
    Citations:    
  95. Tuthill CW, Papkoff J, Watkins BA, Sonis ST. The effect of the immunomodulatory peptide gamma-D-glutamyl-L-tryptophan in leukemia, lymphoma, and head and neck cancer xenograft models. J Clin Oncol. 2011 May 20; 29(15_suppl):5592. PMID: 28022058.
    Citations:    
  96. Rosenthal RA, Fish B, Hill RP, Huffman KD, Lazarova Z, Mahmood J, Medhora M, Molthen R, Moulder JE, Sonis ST, Tofilon PJ, Doctrow SR. Salen Mn complexes mitigate radiation injury in normal tissues. Anticancer Agents Med Chem. 2011 May 01; 11(4):359-72. PMID: 21453241.
    Citations: 30     Fields:    Translation:HumansAnimalsPHPublic Health
  97. Stashenko P, Van Dyke T, Tully P, Kent R, Sonis S, Tanner AC. Inflammation and genetic risk indicators for early periodontitis in adults. J Periodontol. 2011 Apr; 82(4):588-96. PMID: 21054222.
    Citations: 5     Fields:    Translation:Humans
  98. Sonis ST. New thoughts on the initiation of mucositis. Oral Dis. 2010 Oct; 16(7):597-600. PMID: 20846150.
    Citations: 48     Fields:    Translation:HumansCells
  99. Watkins B, Pouliot K, Fey E, Tuthill C, Sonis S. Attenuation of radiation- and chemoradiation-induced mucositis using gamma-D-glutamyl-L-tryptophan (SCV-07). Oral Dis. 2010 Oct; 16(7):655-60. PMID: 20412446.
    Citations: 5     Fields:    Translation:Animals
  100. Murray LA, Kramer MS, Hesson DP, Watkins BA, Fey EG, Argentieri RL, Shaheen F, Knight DA, Sonis ST. Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis. Fibrogenesis Tissue Repair. 2010 Jul 05; 3:11. PMID: 20602770.
    Citations: 14     
  101. Sonis ST. Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core Evid. 2010 Jun 15; 4:199-205. PMID: 20694076.
    Citations: 19     
  102. Caluwaerts S, Vandenbroucke K, Steidler L, Neirynck S, Vanhoenacker P, Corveleyn S, Watkins B, Sonis S, Coulie B, Rottiers P. AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol. 2010 Jul; 46(7):564-70. PMID: 20542722.
    Citations: 33     Fields:    Translation:HumansAnimalsCells
  103. Sonis ST. Regimen-related gastrointestinal toxicities in cancer patients. Curr Opin Support Palliat Care. 2010 Mar; 4(1):26-30. PMID: 20040879.
    Citations: 13     Fields:    Translation:Humans
  104. Fox BS, Sonis S. TNF and oral mucositis: response to effect of selective inhibitors of inflammation on oral mucositis: preclinical studies. Radiother Oncol 2009; 92:472-6. Radiother Oncol. 2010 Jan; 94(1):123; author reply 123-4. PMID: 20079549.
    Citations: 1     Fields:    Translation:HumansAnimals
  105. Sonis S, Treister N, Chawla S, Demetri G, Haluska F. Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients. Cancer. 2010 Jan 01; 116(1):210-5. PMID: 19862817.
    Citations: 35     Fields:    Translation:Humans
  106. Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009 Dec; 45(12):1015-20. PMID: 19828360.
    Citations: 98     Fields:    Translation:HumansAnimals
  107. Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer. 2009 Oct 01; 115(19):4514-23. PMID: 19634161.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  108. Rankin KV, Epstein J, Hubber MA, Peterson DE, Plemons JM, Redding SS, Sanfillippo NJ, Schubert MM, Sonis ST. Oral health in cancer therapy. Todays FDA. 2009 Aug; 21(8):37, 39-45. PMID: 19728463.
    Citations:    Fields:    
  109. Rottiers P, Caluwaerts S, Steidler L, Vandenbroucke K, Watkins B, Sonis S, Coulie B. Effect of a mouth rinse formulation with human trefoil factor 1-secreting Lactococcus lactis in experimental oral mucositis in hamsters. J Clin Oncol. 2009 May 20; 27(15_suppl):e14570. PMID: 27963684.
    Citations:    
  110. Rankin KV, Epstein J, Huber MA, Peterson DE, Plemons JM, Redding SS, Sanfillippo NJ, Schubert MM, Sonis ST. Oral health in cancer therapy. Tex Dent J. 2009 May; 126(5):389-97, 406-19, 422-37. PMID: 19492587.
    Citations: 1     Fields:    Translation:Humans
  111. Lalla RV, Pilbeam CC, Walsh SJ, Sonis ST, Keefe DM, Peterson DE. Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study. Support Care Cancer. 2010 Jan; 18(1):95-103. PMID: 19404685.
    Citations: 17     Fields:    Translation:Humans
  112. Aprile G, Ramoni M, Keefe D, Sonis S. Links between regimen-related toxicities in patients being treated for colorectal cancer. Curr Opin Support Palliat Care. 2009 Mar; 3(1):50-4. PMID: 19365161.
    Citations: 10     Fields:    Translation:Humans
  113. Sonis ST. RE: Wang W, et al. The therapeutic effect of fractionated radiation on DMBA-induced hamster buccal pouch squamous cell carcinomas. Oral Oncol 2008;44:1160-66. Oral Oncol. 2009 Sep; 45(9):840; author reply 841-2. PMID: 19250856.
    Citations:    Fields:    Translation:AnimalsPHPublic Health
  114. Guze K, Short M, Sonis S, Karimbux N, Chan J, Zeng H. Parameters defining the potential applicability of Raman spectroscopy as a diagnostic tool for oral disease. J Biomed Opt. 2009 Jan-Feb; 14(1):014016. PMID: 19256704.
    Citations: 4     Fields:    Translation:Humans
  115. Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer. 2008 Nov 15; 113(10):2704-13. PMID: 18973181.
    Citations: 79     Fields:    Translation:Humans
  116. Keefe DM, Sonis ST, Bowen JM. Emerging drugs for chemotherapy-induced mucositis. Expert Opin Emerg Drugs. 2008 Sep; 13(3):511-22. PMID: 18764726.
    Citations: 14     Fields:    Translation:Humans
  117. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol. 2009 Feb; 45(2):164-72. PMID: 18715819.
    Citations: 61     Fields:    Translation:Animals
  118. Murphy CK, Fey EG, Watkins BA, Wong V, Rothstein D, Sonis ST. Efficacy of superoxide dismutase mimetic M40403 in attenuating radiation-induced oral mucositis in hamsters. Clin Cancer Res. 2008 Jul 01; 14(13):4292-7. PMID: 18594012.
    Citations: 25     Fields:    Translation:AnimalsPHPublic Health
  119. Barasch A, Spijkervet F, Garden A, Kudrimoti MR, Brachman D, Brennan M, Tishler RB, Elting L, Keefe D, Sonis S. Efficacy of opioid analgesics and effect on functional status of pain caused by radiation-induced mucositis among patients with head and neck cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6019. PMID: 27950657.
    Citations:    
  120. Aprile G, Iaiza E, De Pauli F, Zanon E, Foltran L, Mazzer M, Cardellino G, Miscoria M, Fasola G, Sonis S. Geographical differences in acute treatment-related toxicity frequencies: A comparative analysis of 503 colorectal cancer (CRC) patients receiving chemotherapy. J Clin Oncol. 2008 May 20; 26(15_suppl):20561. PMID: 27949799.
    Citations:    
  121. Ara G, Watkins BA, Zhong H, Hawthorne TR, Karkaria CE, Sonis ST, Larochelle WJ. Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. Int J Radiat Biol. 2008 May; 84(5):401-12. PMID: 18464069.
    Citations: 7     Fields:    Translation:HumansAnimalsPHPublic Health
  122. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. . 2008 Jul; 7(7):1139-45. PMID: 18535404.
    Citations: 38     Translation:Animals
  123. Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol. 2009 Jan; 63(2):239-51. PMID: 18351341.
    Citations: 38     Fields:    Translation:Animals
  124. Aprile G, Ramoni M, Keefe D, Sonis S. Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy. Cancer. 2008 Jan 15; 112(2):284-92. PMID: 18041060.
    Citations: 17     Fields:    Translation:Humans
  125. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008 Jan; 52(1):61-77, viii. PMID: 18154865.
    Citations: 100     Fields:    Translation:HumansPHPublic Health
  126. Sonis ST. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007 Oct; 5(9 Suppl 4):3-11. PMID: 18046993.
    Citations: 69     Fields:    Translation:Humans
  127. Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol. 2008 Jun; 62(1):33-41. PMID: 17703303.
    Citations: 54     Fields:    Translation:Animals
  128. Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev. 2007 Aug; 33(5):448-60. PMID: 17507164.
    Citations: 76     Fields:    Translation:HumansAnimals
  129. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol. 2007 May; 5(5):231-5. PMID: 17564153.
    Citations: 10     Fields:    Translation:Humans
  130. Treister N, Sonis S. Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg. 2007 Apr; 15(2):123-9. PMID: 17413415.
    Citations: 26     Fields:    Translation:Humans
  131. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007 Mar 01; 109(5):820-31. PMID: 17236223.
    Citations: 187     Fields:    Translation:Humans
  132. Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer. 2007 May; 15(5):491-6. PMID: 17139495.
    Citations: 29     Fields:    Translation:Humans
  133. Blijlevens N, Sonis S. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Ann Oncol. 2007 May; 18(5):817-26. PMID: 17030544.
    Citations: 41     Fields:    Translation:HumansAnimals
  134. Logan RM, Gibson RJ, Sonis ST, Keefe DM. Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol. 2007 Apr; 43(4):395-401. PMID: 16979925.
    Citations: 45     Fields:    Translation:Humans
  135. Sonis S, Haddad R, Posner M, Watkins B, Fey E, Morgan TV, Mookanamparambil L, Ramoni M. Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol. 2007 Mar; 43(3):289-300. PMID: 16920386.
    Citations: 26     Fields:    Translation:HumansCells
  136. Chambers MS, Welsh DV, Scrimger RA, Zehn W, Epstein JB, Troha J, Sonis ST. RK-0202 for radiation-induced oral mucositis. J Clin Oncol. 2006 Jun 20; 24(18_suppl):5523. PMID: 27954539.
    Citations:    
  137. Sonis ST. Can oral glutamine prevent mucositis in children undergoing hematopoietic stem-cell transplantation? Nat Clin Pract Oncol. 2006 May; 3(5):244-5. PMID: 16683001.
    Citations:    Fields:    
  138. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis. 2006 May; 12(3):229-41. PMID: 16700732.
    Citations: 54     Fields:    Translation:Humans
  139. Tanner AC, Paster BJ, Lu SC, Kanasi E, Kent R, Van Dyke T, Sonis ST. Subgingival and tongue microbiota during early periodontitis. J Dent Res. 2006 Apr; 85(4):318-23. PMID: 16567551.
    Citations: 31     Fields:    Translation:HumansCellsPHPublic Health
  140. Anthony L, Bowen J, Garden A, Hewson I, Sonis S. New thoughts on the pathobiology of regimen-related mucosal injury. Support Care Cancer. 2006 Jun; 14(6):516-8. PMID: 16583189.
    Citations: 13     Fields:    Translation:Humans
  141. Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006 Jan 15; 106(2):329-36. PMID: 16342066.
    Citations: 75     Fields:    Translation:HumansPHPublic Health
  142. Sonis S. New trends in the management of oral mucositis. J Natl Compr Canc Netw. 2005 Nov; 3 Suppl 1:S54-6. PMID: 16280115.
    Citations:    Fields:    Translation:Humans
  143. Hwang D, Popat R, Bragdon C, O'Donnell KE, Sonis ST. Effects of ceramide inhibition on experimental radiation-induced oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Sep; 100(3):321-9. PMID: 16122660.
    Citations: 6     Fields:    Translation:Animals
  144. Stokman MA, Sonis ST, Dijkstra PU, Burgerhof JG, Spijkervet FK. Assessment of oral mucositis in clinical trials: impact of training on evaluators in a multi-centre trial. Eur J Cancer. 2005 Aug; 41(12):1735-8. PMID: 16039109.
    Citations: 3     Fields:    Translation:Humans
  145. Oster G, Vera-Llonch M, Ford C, Khazanov I, Sonis S. Oral mucositis (OM) and outcomes of allogeneic (AL) hematopoietic stem cell transplantation (HSCT). J Clin Oncol. 2005 Jun; 23(16_suppl):6107. PMID: 27945612.
    Citations:    
  146. Sonis ST, Watkins B, Fey E, Yuschak M, Parenti D. Mechanism of action of benzydamine in the treatment of oral mucositis. J Clin Oncol. 2005 Jun; 23(16_suppl):8040. PMID: 27946608.
    Citations:    
  147. Cutler C, Li S, Kim HT, Laglenne P, Szeto KC, Hoffmeister L, Harrison MJ, Ho V, Alyea E, Lee SJ, Soiffer R, Sonis S, Antin JH. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant. 2005 May; 11(5):383-8. PMID: 15846292.
    Citations: 34     Fields:    Translation:Humans
  148. Sonis ST. Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers? Nat Clin Pract Oncol. 2005 Mar; 2(3):134-5. PMID: 16264905.
    Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  149. Alvarez E, Gerlach VL, Gerwien RW, Fey EG, Watkins BA, Hahne WF, Sonis ST. Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05)Reduces the Severity and Duration of Oral Mucositis. Support Cancer Ther. 2005 Jan 01; 2(2):122-7. PMID: 18628199.
    Citations: 2     
  150. Hile DD, Sonis ST, Doherty SA, Tian X, Zhang Q, Jee WS, Trantolo DJ. Dimensional stability of the alveolar ridge after implantation of a bioabsorbable bone graft substitute: a radiographic and histomorphometric study in rats. J Oral Implantol. 2005; 31(2):68-76. PMID: 15871525.
    Citations: 1     Fields:    Translation:HumansAnimals
  151. Sonis ST. Oral mucositis in cancer therapy. J Support Oncol. 2004 Nov-Dec; 2(6 Suppl 3):3-8. PMID: 15605918.
    Citations: 42     Fields:    Translation:Humans
  152. Kang SJ, Popat R, Bragdon C, Odonnell K, Phelan S, Yuan J, Sonis ST. Caspase-11 is not necessary for chemotherapy-induced intestinal mucositis. DNA Cell Biol. 2004 Aug; 23(8):490-5.